Getein Biotech, Inc (603387.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.24B |
| Enterprise Value | 4.41B |
| P/E Ratio | 17.2 |
| PEG Ratio | 0.55 |
| Price/Sales Ratio | 3.75 |
| Price/Book Ratio | 1.42 |
| Enterprise/Revenue | 3.89 |
| Enterprise/EBITDA | 13.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.22 |
| Operating Margin | 0.21 |
| Return On Assets | 0.06 |
| Return On Equity | 0.08 |
| Revenue | 1.04B |
| Revenue/Share | 2.12 |
| Gross Profit | 658.97M |
| EBITDA | 329.57M |
| Net Income | 220.66M |
| Diluted EPS | 0.44 |
| Total Cash | 1.36B |
| Total Cash/Share | 2.68 |
| Total Debt | 401.72M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 3.21 |
| Book Value Per Share | 5.78 |
| 52-Week Change | 2.19 |
| 52-Week High | 11.42 |
| 52-Week Low | 7.62 |
| Moving Average 50 Days | 9.18 |
| Moving Average 200 Days | 8.71 |
| Average Volume | 22.85M |
| Shares Outstanding | 507.15M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.24 |
| Trailing Annual Dividend Yield | 3.02 |
| Payout Ratio | 0.61 |
| Last Split Factor | 7:5 |
| Last Split Date | June 08, 2022 |